Page 30 - Fluorescence-guided cancer surgery

28 Chapter 2
Table 2. Characteristics of detected SLNs
Patient no.
T Tumor stage location
Pre- Number of operative detected
Location of detected SLNs by LN St
Mean SBR of SLNs
Tumor SLN status in Identi cation
SLN outside Standard dissection plane?
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
1 M 4 M 4 D 1 D 2 U 3 M 1 M 2 U 3 U 3 D 3 D 4 U 2 U 2 D 2 M 4 M 3 U 3 D x D x D 3 M
No 33
Yes 3 3; 3 and 6
Yes No tracer injected because of metastasized disease. Yes 3 4; 6 and 6
Yes 4 3; 3; 4 and 4
Yes 3 4; 4 and 7
No 4 3; 3; 6 and 6
Yes Technical failure of tracer administration
5.4 1.9
Neg Yes Pos No
No No
22 23 24 25 26
3 D 3 U 3 D 1 D 1 D
Yes 4 Yes 1 Yes 6 Yes 4 Yes 4
3; 6; 6 and 14
1
3; 3; 6; 6; 6 and 11 3; 3; 4 and 6
5; 6; 6 and 6
3.1 Pos Yes 6.2 Pos Yes 4.0 Pos Yes 4.6 Neg Yes 5.6 Neg Yes
Yes No Yes No No
CTx SLNs
SLNs accurate?
Yes 2
No 3
Yes 4
Yes No tracer injected because of metastasized disease. Yes 3 1; 7 and 9
8.7 4.7 4.9
Neg Yes Pos No Pos Yes
No Yes Yes
Yes 2 Yes 2 Yes 2 Yes 2 Yes 5
8 and 12
5 and 6
3 and 3
3 and 14
3; 3; outside standard planes of 9 (3x)
2.6 Neg Yes 11.4 Neg Yes 3.6 Neg Yes 3.6 Neg Yes 2.8 Pos Yes
Yes No No Yes Yes
1 and 1
6; 6 and 12 5; 6; 6 and 12
Yes 4 6 and 12
Yes 0 N/A
Yes No tracer injected because of metastasized disease.
3.5 5.1
Abbreviations: CTx, Chemotherapy; D, antrum of stomach; LN, Lymph Node; M, corpus of stomach; N/A, Not Applicable; SBR, Signal-to-Background Ratio; SLN, Sentinel Lymph Node; St, Lymph node station according to Japanese Research Society for the Study of Gastric Cancer; U, cardia of stomach;
4.3 3.9 5.3 3.1
Neg Yes Neg Yes Neg Yes Neg Yes
No No No No
Neg Yes Pos Yes N/A N/A N/A
No Yes No